Loading...

LBT Innovations Limited

LBT.AXASX
Healthcare
Medical - Devices
A$0.02
A$0.00(0.00%)

LBT Innovations Limited (LBT.AX) Company Profile & Overview

Explore LBT Innovations Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

LBT Innovations Limited (LBT.AX) Company Profile & Overview

LBT Innovations Limited engages in the research, development, and commercialization of technologies for the healthcare and laboratory supply markets in Australia, Switzerland, the United States, the United Kingdom, and Germany. The company offers MicroStreak, an automated culture-plate streaking and inoculation system; and Automated Plate Assessment System, a platform technology that automates culture-plate screening and interpretation. It also develops Automated Gram Strain Assessment for the automated interpretation of gram stain image analysis; WoundVue, a technology that uses artificial intelligence to assist clinicians in the assessment and care of chronic wounds; Automated Plate Assessment System Pharma, a technology that uses cutting-edge artificial intelligent image analysis algorithms to automatically detect microbial growth for environmental monitoring applications; and devices that can detect biofilms in the presence of mammalian tissue. The company was incorporated in 2004 and is headquartered in Adelaide, Australia.

SectorHealthcare
IndustryMedical - Devices
CEOBrenton John Barnes

Contact Information

61 8 8227 1555
16 Anster Street, Adelaide, SA, 5000

Company Facts

19 Employees
IPO DateJul 21, 2006
CountryAU

Frequently Asked Questions

;